Compare · BTN vs TMO
BTN vs TMO
Side-by-side comparison of Ballantyne Strong Inc. (BTN) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BTN operates in Consumer Discretionary, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $183.60B, about 3600.6x BTN ($51.0M).
- TMO has hit the wire 17 times in the past 4 weeks while BTN has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for BTN).
- Company
- Ballantyne Strong Inc.
- Thermo Fisher Scientific Inc
- Price
- $2.40-12.73%
- $493.55+0.20%
- Market cap
- $51.0M
- $183.60B
- 1M return
- -
- +2.96%
- 1Y return
- -
- +24.50%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- News (4w)
- 0
- 17
- Recent ratings
- 0
- 25
Ballantyne Strong Inc.
Ballantyne Strong, Inc. operates in the entertainment industry worldwide. The company manufactures and sells projection screens and customized screen support systems directly, as well as through third-party distributors and integrators. It also manufactures and distributes curvilinear immersive screens to theme parks, museums, and schools, as well as for special events and military applications. In addition, the company provides digital projection equipment installations and after-sale maintenance and network support services directly to theater owners and other entertainment-related markets, as well as through dealers or value added reseller networks. Further, it distributes and supports third party products, including digital projectors, servers, library management systems, menu boards, sound systems, lenses, and lamps. Ballantyne Strong, Inc. was founded in 1932 and is headquartered in Charlotte, North Carolina.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BTN
- SEC Form SC 13G/A filed by Ballantyne Strong Inc. (Amendment)
- SEC Form DEFM14A filed by Ballantyne Strong Inc.
- SEC Form 8-K filed by Ballantyne Strong Inc.
- Ballantyne Strong Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Ballantyne Strong Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by Ballantyne Strong Inc.
- Ballantyne Strong Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Ballantyne Strong Inc.
- SEC Form DEF 14A filed by Ballantyne Strong Inc.
- SEC Form 10-Q filed by Ballantyne Strong Inc.
Latest TMO
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
- Director Johnson Jennifer M was granted 499 shares, increasing direct ownership by 55% to 1,403 units (SEC Form 4)
- Director Jacks Tyler was granted 499 shares, increasing direct ownership by 6% to 9,462 units (SEC Form 4)